Viewing Study NCT01283035


Ignite Creation Date: 2025-12-24 @ 10:04 PM
Ignite Modification Date: 2026-02-03 @ 1:37 PM
Study NCT ID: NCT01283035
Status: COMPLETED
Last Update Posted: 2016-06-24
First Post: 2011-01-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Sarcoma View
None Recurrent Fallopian Tube Carcinoma View
None Recurrent Ovarian Carcinoma View
None Recurrent Primary Peritoneal Carcinoma View
Keywords: